Mamaling, Policarpio V.
HRN: 08-42-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/04/2025
10/11/2025
IV
500mg
Q8h
T/C AP
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes